Immunitybio Contact Us
Contact Us ImmunityBio
WebContact Us. For ImmunityBio Medical Information, or to report an Adverse Event or Product Complaint, please email us here. For additional information on ImmunityBio, please email us here. Office Locations. San Diego, CA. 3530 John Hopkins Court San …
See Also: Immunity bio contact number Preview / Show details
Immunotherapy by ImmunityBio Cancer Vaccine …
WebMay 2, 2024 · Opportunities for Trial Investigators The broad therapeutic potential and demonstrated safety of ImmunityBio’s immune-enhancing IL-15 superagonist Anktiva (N-803), engineered NK-92® cell-based …
See Also: Cell Phone Preview / Show details
Contact Us ImmunityBio, Inc.
WebThe Investor Relations website contains information about ImmunityBio, Inc.'s business for stockholders, potential investors, and financial analysts.
See Also: Contact Support Preview / Show details
Investor Relations ImmunityBio, Inc.
844-696-5235 WebApr 22, 2024 · Contact Us; ImmunityBio.com; Investor Relations. IR Contact. ImmunityBio Investor Relations. Phone: 1-844-696-5235, Option 5 Email. Transfer …
See Also: Phone Number Preview / Show details
Medical Studies & Immunotherapies Advanced …
WebSoon-Shiong turned his focus to the next-generation of immunotherapies. ImmunityBio was founded in 2014 to create innovative immunotherapies that address serious unmet needs in oncology and infectious disease. …
See Also: Medical Preview / Show details
ImmunityBio, Inc. LinkedIn
WebAbout us. ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural …
See Also: Cell Phone Preview / Show details
ImmunityBio, Inc.: Contact Details and Business Profile
WebImmunityBio was founded in 2014 to create innovative immunotherapies that address serious unmet needs in oncology and infectious diseases. "At ImmunityBio, we envision …
See Also: Contact Support Preview / Show details
ImmunityBio Announces Full Accrual of First Two Phases of Cancer
WebFeb 21, 2024 · More details about these and other risks that may impact ImmunityBio’s business are described under the heading “Risk Factors” in the Company’s Form 10-K …
See Also: Business Preview / Show details
ImmunityBio Expands Vaccine Program to Accelerate Use of “Mix …
WebNov 18, 2021 · More details about these and other risks that may impact ImmunityBio’s business are described under the heading “Risk Factors” in the Company’s Form 8-K …
See Also: Business Preview / Show details
ImmunityBio Announces FDA Approval of ANKTIVA®, Firstin …
WebApr 22, 2024 · ImmunityBio management will discuss FDA approval of ANKTIVA in combination with BCG for the treatment of BCG-unresponsive NMIBC via a conference …
See Also: Atm Preview / Show details
Fighting a war on two fronts: ImmunityBio targets cancer and
WebImmunityBio is applying its second-generation human adenovirus 5 vaccine platform, used as part of its orchestrated multi-modal treatment approach to advanced cancer, to …
See Also: Atm Preview / Show details
ImmunityBio Announces Full Accrual of First Two Phases of Cancer
WebFeb 21, 2024 · CULVER CITY, Calif., February 21, 2024--ImmunityBio (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that enrollment and initial …
See Also: Phone Number Preview / Show details
ImmunityBio Completes GMP Drug Substance Manufacturing …
Web2 days ago · Contact Us; ImmunityBio.com; Press Release. ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®
See Also: Contact Support Preview / Show details
IMMUNITYBIO, INC. Company Profile Culver City, CA
WebFind company research, competitor information, contact details & financial data for IMMUNITYBIO, INC. of Culver City, CA. Get the latest business insights from Dun & …
See Also: Contact Support Preview / Show details
US FDA approves ImmunityBio's bladder cancer therapy
WebApr 23, 2024 · The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder cancer, marking an end to the company's efforts to …
See Also: Health Preview / Show details
ImmunityBio, Inc. Name of contact for additional information …
844-696-5235 Web3 Name of contact for additional information 4 Telephone No. of contact 5 Email address of contact ImmunityBio, Inc. 36-4798272 Investor Relations Desk 1-844-696-5235, …
See Also: Phone Number Preview / Show details
Privacy Policy ImmunityBio
310-883-1300 WebDec 9, 2020 · Phone: 1-310-883-1300. Email: info@ImmunityBio.com. ImmunityBio, Inc. (“Company”) recognizes the importance of protecting the privacy of information we may …
See Also: Phone Number Preview / Show details